The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

MMRF Recognizes Two Outstanding Organizations at 58th ASH Annual Meeting

The Multiple Myeloma Research Foundation (MMRF) announced at the 57th ASH Annual Meeting the recipients of its three awards for outstanding acceleration, innovation and collaboration to advance the research and development of novel therapies for multiple myeloma. Each year, the MMRF recognizes the exceptional work of its partners from industry and academia who have played a critical role toward fulfilling the mission of the MMRF: to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. READ MORE

Posted: December 02, 2016

Resources from the 2016 MMRF ASH Satellite Symposium

The multiple myeloma (MM) therapeutic landscape has significantly expanded, with 10 new drug approvals in the last 12 years. To help hematologist-oncologists keep pace with the rapid advancements in treatments, this satellite symposium will provided updated information on the optimal strategies for managing patients with MM. READ MORE

Posted: December 02, 2016

Groundbreaking MMRF CoMMpass Study℠ Affirmed as Premier Genomics Data Set in Multiple Myeloma

The Multiple Myeloma Research Foundation (MMRF) today announced that 19 research presentations from the MMRF CoMMpass StudySM—the largest and most comprehensive study driving new genomic insights and accelerating precision medicine in multiple myeloma—will be presented at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego from December 3-6. READ MORE

Posted: December 01, 2016

Page 12 of 87« First...1011121314...203040...Last »